BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28814453)

  • 21. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
    Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS
    Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biology and clinical implications of prostate cancer dormancy and metastasis.
    Morrissey C; Vessella RL; Lange PH; Lam HM
    J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis.
    Ma Y; Krueger JJ; Redmon SN; Uppuganti S; Nyman JS; Hahn MK; Elefteriou F
    J Biol Chem; 2013 Oct; 288(42):30105-30113. PubMed ID: 24005671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
    Ruppender N; Larson S; Lakely B; Kollath L; Brown L; Coleman I; Coleman R; Nguyen H; Nelson PS; Corey E; Snyder LA; Vessella RL; Morrissey C; Lam HM
    PLoS One; 2015; 10(6):e0130565. PubMed ID: 26090669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.
    Schwaninger R; Rentsch CA; Wetterwald A; van der Horst G; van Bezooijen RL; van der Pluijm G; Löwik CW; Ackermann K; Pyerin W; Hamdy FC; Thalmann GN; Cecchini MG
    Am J Pathol; 2007 Jan; 170(1):160-75. PubMed ID: 17200191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis.
    Dai R; Liu M; Xiang X; Xi Z; Xu H
    J Exp Clin Cancer Res; 2022 Oct; 41(1):316. PubMed ID: 36307871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer.
    Todenhöfer T; Hennenlotter J; Faber F; Wallwiener D; Schilling D; Kühs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Fehm T; Stenzl A; Schwentner C
    Prostate; 2015 May; 75(6):637-45. PubMed ID: 25586166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.
    Lerman I; Garcia-Hernandez ML; Rangel-Moreno J; Chiriboga L; Pan C; Nastiuk KL; Krolewski JJ; Sen A; Hammes SR
    Mol Cancer Res; 2017 Sep; 15(9):1138-1152. PubMed ID: 28512253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
    Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
    Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.
    Katayama Y; Battista M; Kao WM; Hidalgo A; Peired AJ; Thomas SA; Frenette PS
    Cell; 2006 Jan; 124(2):407-21. PubMed ID: 16439213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
    BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.
    Reichert JC; Quent VM; Burke LJ; Stansfield SH; Clements JA; Hutmacher DW
    Biomaterials; 2010 Nov; 31(31):7928-36. PubMed ID: 20688384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin in prostate cancer bone metastasis.
    Corey E; Brown LG; Kiefer JA; Quinn JE; Pitts TE; Blair JM; Vessella RL
    Cancer Res; 2005 Mar; 65(5):1710-8. PubMed ID: 15753366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes.
    Gužvić M; Braun B; Ganzer R; Burger M; Nerlich M; Winkler S; Werner-Klein M; Czyż ZT; Polzer B; Klein CA
    Cancer Res; 2014 Dec; 74(24):7383-94. PubMed ID: 25320011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular insights of Gas6/TAM in cancer development and therapy.
    Wu G; Ma Z; Hu W; Wang D; Gong B; Fan C; Jiang S; Li T; Gao J; Yang Y
    Cell Death Dis; 2017 Mar; 8(3):e2700. PubMed ID: 28333143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.